Technology Transfer

Dec 06, 2017
By BioPharm International Editors
A survey by LNS Research and sponsored by Honeywell showed that industrial companies are not moving quickly to adopt cyber security; calls on CEOs to take action.
Dec 01, 2017
BioPharm International
A technology roadmap aims to drive and consolidate improvements in a process that has remained unchanged for more than 70 years.
Nov 28, 2017
By BioPharm International Editors
The acquisition gives GE Healthcare access to a nanofiber-based platform purification technology that can offer improvements in biopharmaceutical productivity.
Nov 15, 2017
BioPharm International
This article explores some of the challenges, services, and technologies that go into ensuring that vaccines are properly temperature controlled and maintain product integrity for delivery to patients.
Oct 24, 2017
By BioPharm International Editors
How soon could the pharmaceutical industry see a widespread adoption of emerging technologies that are poised to shape its future?
Oct 23, 2017
By BioPharm International Editors
The $72-million investment, part of a larger $850-million investment into its US operations, will allow the drugmaker to replace an outdated insulin vial-filling line and to upgrade technology at its Indianapolis manufacturing plant.
May 15, 2017
BioPharm International
Good project management, budgeting, planning, and clear documentation are the only ways to prevent overruns and project failure.
Mar 01, 2017
BioPharm International
Communication and taking the time to develop the process are key to successful transfer and scale up of biologics
Mar 01, 2017
Sponsored Content
For analysis of rituximab charge variants, method transfer between the Agilent 1260 Infinity Bio-Inert LC and the Agilent 1260 Infinity II Bio-Inert LC produced equivalent results.
Oct 15, 2016
BioPharm International
Classical production in cell-based systems such as mammalian and bacterial cells requires cell line development and lengthy process development to support scale-up. With plant technology, generic plant bioreactors can be grown rapidly and then transfected with a transient vector based system to produce proteins in days. Large-scale commercial facilities are now available in the US, enabling clinical or commercial production of significant quantities of therapeutic materials within a year.
native1_300x100
lorem ipsum